May 04, 2007 09:27 ET

Emerging Equity Alert for Friday, May 04, 2007: LDPH New Consulting Agreement With AngioGenex Inc.!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL--(Marketwire - May 4, 2007) - Announces the following stocks to its Breaking News List: London & Pacific Healthcare, Inc. (PINKSHEETS: LDPH), Axcelis Technologies, Inc. (NASDAQ: ACLS), Optionable, Inc. (OTCBB: OPBL), General Metals Corporation (OTCBB: GNLM).

London & Pacific Healthcare, Inc. (PINKSHEETS: LDPH), a corporate finance and development company working with a select group of healthcare companies, just announced that it has executed a consulting agreement with New York-based AngioGenex, Inc. The Company will assist AngioGenex in attracting investment capital from India.

"We are extremely excited for this opportunity to work alongside a dynamic bio-technology company such as AngioGenex," commented Stuart Bruck, Executive Chairman and CEO of London & Pacific. He continued, "There are many companies in the Indian market looking to establish alliances with innovative and progressive companies in the West, and London & Pacific can serve as an excellent bridge to these valuable, new relationships." has just begun a long-term financial public relations and communications campaign for LDPH and we are expecting a great deal of success to come of this new relationship with a growing healthcare services company. Investors who want to get in on an emerging healthcare play with strong prospects in a trillion dollar industry, and headed by an enterprising management team, should be looking at LDPH now!

Other stocks highlighted include Axcelis Technologies, Inc. (NASDAQ: ACLS): Hot Stocks List, down 19% on 7 million shares, Optionable, Inc. (OTCBB: OPBL): Hot Stocks List, down 18% on 5 million shares, General Metals Corporation (OTCBB: GNLM): Hot Stocks List, up 18% on 6 million shares.'s Daily Stock Updates:, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to Daily Ranking is consistently ranked in the top 4 on the "Best performing promoters of all time" list. This is out of over 1,000 promoters and promotional campaigns tracked by Visit for more details.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated one hundred fifty thousand shares for LDPH. CRGP has also purchased five thousand shares in the open market. CRGP intends to sell its shares. CRGP has sold approximately zero LDPH shares to date. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site are operated under a license from Capital Research Group, Inc., Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information